Morpholine → HCID 67550430, compound
Reaction equation
[C:1]1([CH:7]=[CH:8][C:9]([NH:11][C@H:12]([C:14]2[CH:19]=[CH:18][CH:17]=[C:16](OS(C(F)(F)F)(=O)=O)[CH:15]=2)[CH3:13])=[O:10])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.P([O-])([O-])([O-])=O.[K+].[K+].[K+].[NH:36]1[CH2:41][CH2:40][O:39][CH2:38][CH2:37]1>COCCOC.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[C:1]1([CH:7]=[CH:8][C:9]([NH:11][C@H:12]([C:14]2[CH:19]=[CH:18][CH:17]=[C:16]([N:36]3[CH2:41][CH2:40][O:39][CH2:38][CH2:37]3)[CH:15]=2)[CH3:13])=[O:10])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1Participants
6
Conditions
- Temperature
- 80 °C
Procedure
To a solution of (S)-3-phenyl-N-[1-(3-trifluoromethanesulfonyloxy-phenyl)-ethyl]acrylamide (50 mg) in DME (0.5 mL) at room temperature was added Pd2(dba)3 (29 mg), potassium phosphate (37 mg), morpholine (0.02 mL), and the resulting suspension was heated at 80° C. for 15 hours. The solvent was removed in vacuo, and the residue was purified by preparative HPLC to afford the title compound as the trifluoacetic acid salt.
Workup
- customThe solvent was removed in vacuo
- customthe residue was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-7bc78ec4c08243efb94d1f83adc5c008
- Source dataset
- uspto-grants-2004_12
- Patent number
- US06831080B2
Reaction notes
Loading…